Gastric Gastroesophageal Junction Adenocarcinoma

• CLINICAL_TRIALS research · 2025-08-29
  Clinical Trial Update: Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]

  A Phase 2 clinical trial evaluating a combination of immunotherapy, anti-angiogenic therapy, and chemotherapy for gastric/gastroesophageal j…

• CLINICAL_TRIALS research · 2025-01-09
  Clinical Trial Update: Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]

  A Phase 2 neoadjuvant trial evaluating low-dose interval radiotherapy combined with Tirelizumab and SOX chemotherapy for locally advanced ga…

• CLINICAL_TRIALS trial_result · 2024-03-20
  Clinical Trial Update: Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]

  Phase 2 clinical trial update for IBI343 in advanced gastric/gastroesophageal junction adenocarcinoma (no current status).

• CLINICAL_TRIALS trial_result · 2024-01-26
  Clinical Trial Update: Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]

  Phase 3 clinical trial comparing modified XELOX plus sintilimab versus standard XELOX plus sintilimab as first-line therapy for HER2-negativ…

• CLINICAL_TRIALS trial_result · 2023-09-11
  Clinical Trial Update: Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin [Phase 2]

  Phase 2 trial update on a second-line treatment combining Envafolimab, Lenvatinib, and Paclitaxel-albumin for advanced gastric/gastroesophag…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-05-24
  Clinical Trial Update: Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric [Phase 2]

  Phase 2 trial evaluating preoperative short-course radiotherapy combined with Envafolimab, Endostatin, and the SOX regimen for locally advan…